Companies: 10,795·Total market cap: $144.5T
Biotest AG

Biotest AG

BTTAYOTCHealthcare
$24.23
+$0.00(+0.00%)
Market Cap$943029783
P/E Ratio
52W High$24.27
52W Low$22.8

Biotest AG (BTTAY) Dividends

TTM yield, annualized payout, frequency and payout ratio — history, chart and FAQs below.

FMP · BTTAY · as of Jun 9, 2025

Key dividend metrics

Dividend YieldTTM
Annual Payout$0.0138per share
Payout FrequencyIrregular
Payout Ratioof earnings distributed

Dividend Reliability

Variable
Consecutive payments
No interruptions
4/4 recent on schedule
Latest vs previous
Stable
Payment frequency
On track
1 payments / 12 months
Days since last payment
337 days ago
Overdue
1 years consecutiveBased on historical dividend behavior. Past payments do not guarantee future distributions.

Most Recent Dividend

$0.0138per share
Ex-Dividend DateJul 7, 2025337 days agoMust hold before this date
Record DateJul 7, 2025Shareholder of record
Pay DateJul 22, 2025Payment received
Est. next: Jan 5, 2026·Irregular · based on historical pattern

Annual dividends per share

Dividend history

Ex-dateAmountRecord datePay dateYoY
Jul 7, 2025$0.0138Jul 7, 2025Jul 22, 2025

Dividend history & analysis

Biotest AG (BTTAY) currently pays a Irregular dividend of $$0.0138 per share, with an annual payout of $0.0138 and a dividend yield of —%. The company has maintained a consistent dividend payment record, making it a popular choice among income-focused investors.

The most recent ex-dividend date was July 7, 2025. Investors who held BTTAY shares before this date received the latest dividend payment on July 22, 2025. All historical dividend data on this page is sourced from Financial Modeling Prep and reflects split-adjusted figures where applicable.

Frequently asked questions

Biotest AG pays $$0.0138 per share each period, totaling approximately $0.0138 per share annually. The current dividend yield is —%.

BTTAY dividendBTTAY dividend yielddividend per shareannual dividend income
Data: Financial Modeling Prep · Updated hourly · For informational purposes only, not investment advice.